Effect of endogenous and exogenous prostaglandin E on Friend erythroleukaemia cell growth and differentiation
- PMID: 223618
- PMCID: PMC2009887
- DOI: 10.1038/bjc.1979.49
Effect of endogenous and exogenous prostaglandin E on Friend erythroleukaemia cell growth and differentiation
Abstract
The effect of exogenous and endogenous prostaglandins on the patterns of growth and differentiation of Friend erythroleukaemia cells (FLC) were studied. During the differentiation process, DMSO stimulated PGE synthesis by an average of 95%. The addition of a long-acting synthetic analogue of PGE2,16,16-dimethyl-PGE2-methyl ester (di-M-PGE2) to the culture medium only slightly and temporarily slowed cell growth, with no appreciable induction of differentiation. However, in the presence of DMSO, the same concentration of di-M-PGE2 produced 73% inhibition of cell growth and accelerated and potently stimulated haemoglobin production. The action of both di-M-PGE2 and DMSO on cell proliferation was dependent upon the state of cell growth at the time of the administration of these compounds. FLC cultures treated with DMSO + di-M-PGE2 produced considerable amounts of haemoglobin before even one duplication cycle was completed. Both DMSO and di-M-PGE2 stimulated endogenous PGE biosynthesis, and the biosynthetic effect of these compounds was synergistic. Inhibition of endogenous prostaglandin synthesis by indomethacin completely abolished the effects produced by DMSO + di-M-PGE2 on the growth, and substantially reduced the stimulated differentiation of FLC. These data suggest that an endogenously synthesized prostaglandin plays a significant role in both the inhibition of replication and in the stimulation of differentiation induced by DMSO and di-M-PGE2 in Friend erythroleukaemia cells.
Similar articles
-
Growth inhibition of Friend erythroleukaemia cell tumours in vivo by a synthetic analogue of prostaglandin A: an action independent of natural killer-activity.Br J Cancer. 1990 Mar;61(3):394-9. doi: 10.1038/bjc.1990.86. Br J Cancer. 1990. PMID: 2328205 Free PMC article.
-
Inhibition of Friend erythroleukaemia-cell tumours in vivo by a synthetic analogue of prostaglandin E2.Br J Cancer. 1979 Apr;39(4):408-13. doi: 10.1038/bjc.1979.73. Br J Cancer. 1979. PMID: 286604 Free PMC article.
-
Prostaglandin A1 induces differentiation in Friend erythroleukemia cells.Prostaglandins. 1979 May;17(5):719-27. doi: 10.1016/s0090-6980(79)80043-x. Prostaglandins. 1979. PMID: 291073
-
Viral reverse transcriptase suppression associated with erythroid differentiation of Friend leukemia cells.J Natl Cancer Inst. 1977 Mar;58(3):635-40. doi: 10.1093/jnci/58.3.635. J Natl Cancer Inst. 1977. PMID: 65477
-
Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization.Cell Death Differ. 1999 Feb;6(2):166-74. doi: 10.1038/sj.cdd.4400466. Cell Death Differ. 1999. PMID: 10200563
Cited by
-
Factors affecting the CEA secretion of human adenocarcinoma cell lines into the spent medium.Gastroenterol Jpn. 1983 Oct;18(5):428-35. doi: 10.1007/BF02776581. Gastroenterol Jpn. 1983. PMID: 6317508
-
Growth inhibition of Friend erythroleukaemia cell tumours in vivo by a synthetic analogue of prostaglandin A: an action independent of natural killer-activity.Br J Cancer. 1990 Mar;61(3):394-9. doi: 10.1038/bjc.1990.86. Br J Cancer. 1990. PMID: 2328205 Free PMC article.
-
Inhibition of Friend erythroleukaemia-cell tumours in vivo by a synthetic analogue of prostaglandin E2.Br J Cancer. 1979 Apr;39(4):408-13. doi: 10.1038/bjc.1979.73. Br J Cancer. 1979. PMID: 286604 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources